Amiodarone pulmonary toxicity is one of the most important examples of drug-induced lung
disease by non-cancer chemotherapeutic agents. Current concepts suggest that patients …

Amiodarone is frequently used for the treatment of cardiac arrhythmias. Although the
therapeutic efficacy of amiodarone has been established, its use is limited by its safety …

In a prospective study of lung function of 34 patients taking amiodarone, 24 showed no
functional changes but 10 developed a sustained fall in CO transfer factor (TLCO) exceeding …

Amiodarone, a bi-iodinated benzofuran derivative, is, because of its high effectiveness, one
of the most widely used antiarrhythmic agents. However, adverse effects, especially …

Several forms of pulmonary disease occur among patients treated with amiodarone, ie
chronic interstitial pneumonitis, organizing pneumonia, ARDS, a solitary pulmonary mass of …

Conclusions Since the discovery of amiodarone over 30 years ago, the mechanisms
underlying serious adverse effects remain to be resolved and still limit drug usefulness …

HYDROCHLORIDE, a benzofurone derivative, has been used since 1969 for the control of
cardiac arrhythmias in the United States. It appears to be uniquely effective for some patients …

Amiodarone, a benzofuran derivative, has proven useful in the control of serious cardiac
arrhythmias. We reviewed the English language medical literature to characterize clinical …

Amiodarone-induced pulmonary toxicity has been described mostly in patients receiving
large doses of the drug over prolonged periods. In this report, we describe the early onset of …

Problems with pulmonary toxicity have emerged as a potentially limiting factor for
amiodarone use. We prospectively studied 33 subjects treated with amiodarone for …